• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION MEDTRONIC TRANSCATHETER VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION MEDTRONIC TRANSCATHETER VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV Back to Search Results
Model Number MDT-TRANS VALVE
Device Problems Perivalvular Leak (1457); Patient Device Interaction Problem (4001); Migration (4003); Central Regurgitation (4068)
Patient Problems Non specific EKG/ECG Changes (1817); Hemorrhage/Bleeding (1888); Myocardial Infarction (1969); Cardiac Tamponade (2226); Cardiovascular Insufficiency (4445); Valvular Insufficiency/ Regurgitation (4449); Aortic Valve Insufficiency/ Regurgitation (4450)
Event Date 03/04/2024
Event Type  Injury  
Manufacturer Narrative
Citation: mas-peiro et al.Optimal oversizing in transcatheter aortic valve replacement with the self-expanding evolut valve system.J invasive cardiol.2024 mar 4.Doi: 10.25270/jic/24.00011.Earliest date of publication used for date of event.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.Select patient information cannot be included in regulatory report due to regional privacy regulations.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
Literature was reviewed regarding optimal oversizing in transcatheter aortic valve replacement (tavr) with the medtronic evolut valve.The study population included 740 patients with a mean age of 83.9 years who were predominantly female.  all patients were implanted with a medtronic evolut r, evolut pro or evolut pro+ bioprosthetic valve.  there were three (0.4%) procedural and 20 (2.7%) in-hospital deaths that occurred in the study population.  no further details were provided on these deaths.  of note, there was no statement establishing a causal or contributory relationship between medtronic product and the deaths.  adverse events included: cardiac tamponade, coronary obstruction, valve migration, acute kidney injury, major vascular complication, major bleeding complication, arrhythmia requiring permanent pacemaker implant, moderate to severe paravalvular leak, moderate to severe aortic regurgitation, myocardial infarction, and conversion to open surgery.  no further information was provided pertaining to medtronic products.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MEDTRONIC TRANSCATHETER VALVE
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key18955485
MDR Text Key338302887
Report Number2025587-2024-01833
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
P130021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 03/21/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/21/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberMDT-TRANS VALVE
Device Catalogue NumberMDT-TRANS VALVE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/13/2024
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Hospitalization; Required Intervention;
-
-